Articles with public access mandates - Hartmut DöhnerLearn more
Not available anywhere: 36
Review
Genomics of acute myeloid leukemia diagnosis and pathways
L Bullinger, K Döhner, H Döhner
Journal of clinical oncology 35 (9), 934-946, 2017
Mandates: German Research Foundation
Review
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features
VI Gaidzik, V Teleanu, E Papaemmanuil, D Weber, P Paschka, J Hahn, ...
Leukemia 30 (11), 2160-2168, 2016
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Review
Minimal residual disease assessment improves prediction of outcome in patients with chronic lymphocytic leukemia (CLL) who achieve partial response: comprehensive analysis of …
G Kovacs, S Robrecht, AM Fink, J Bahlo, P Cramer, J von Tresckow, ...
Journal of Clinical Oncology 34 (31), 3758-3765, 2016
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Review
Towards precision medicine for AML
H Döhner, AH Wei, B Löwenberg
Nature reviews Clinical oncology 18 (9), 577-590, 2021
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Review
Impact of serum storage conditions on microRNA stability
S Grasedieck, N Schöler, M Bommer, JH Niess, H Tumani, A Rouhi, ...
Leukemia 26 (11), 2414-2416, 2012
Mandates: German Research Foundation
Review
Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide …
L Bullinger, J Krönke, C Schön, I Radtke, K Urlbauer, U Botzenhardt, ...
Leukemia 24 (2), 438-449, 2010
Mandates: German Research Foundation
Review
Analysis of 11q22–q23 deletion target genes in B-cell chronic lymphocytic leukaemia: Evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B
C Kalla, MO Scheuermann, I Kube, M Schlotter, D Mertens, H Döhner, ...
European journal of cancer 43 (8), 1328-1335, 2007
Mandates: German Research Foundation
Review
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure
M Wattad, D Weber, K Doehner, J Krauter, VI Gaidzik, P Paschka, ...
Leukemia 31 (6), 1306-1313, 2017
Mandates: Federal Ministry of Education and Research, Germany
Review
Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7
S Fröhling, DB Lipka, S Kayser, C Scholl, RF Schlenk, H Döhner, ...
Blood 107 (3), 1242-1243, 2006
Mandates: German Research Foundation
Review
Valproate and retinoic acid in combination with decitabine in elderly nonfit patients with acute myeloid leukemia: results of a multicenter, randomized, 2× 2, phase II trial
M Lübbert, O Grishina, C Schmoor, RF Schlenk, E Jost, M Crysandt, ...
Journal of Clinical Oncology 38 (3), 257-270, 2020
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Review
Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1 mut)
J Greiner, V Schneider, M Schmitt, M Götz, K Döhner, M Wiesneth, ...
Blood, The Journal of the American Society of Hematology 122 (6), 1087-1088, 2013
Mandates: German Research Foundation
Review
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia
VI Gaidzik, D Weber, P Paschka, A Kaumanns, S Krieger, A Corbacioglu, ...
Leukemia 32 (1), 30-37, 2018
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Review
Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors
D Kienle, T Katzenberger, G Ott, D Saupe, A Benner, H Kohlhammer, ...
Journal of clinical oncology 25 (19), 2770-2777, 2007
Mandates: German Research Foundation
Review
Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance
FG Rücker, AC Russ, S Cocciardi, H Kett, RF Schlenk, U Botzenhardt, ...
Leukemia 27 (2), 353-361, 2013
Mandates: German Research Foundation
Review
IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma …
J Krönke, F Kuchenbauer, M Kull, V Teleanu, L Bullinger, D Bunjes, ...
Leukemia 31 (6), 1363-1367, 2017
Mandates: German Research Foundation, European Commission
Review
Donor Lymphocyte Infusion Induces Polyspecific CD8+ T-Cell Responses With Concurrent Molecular Remission in Acute Myeloid Leukemia With NPM1 Mutation
S Hofmann, M Götz, V Schneider, P Guillaume, D Bunjes, H Döhner, ...
Journal of Clinical Oncology 31 (3), e44-e47, 2013
Mandates: German Research Foundation
Review
Chronic lymphocytic leukemia with mutated IGHV4-34 receptors: shared and distinct immunogenetic features and clinical outcomes
A Xochelli, P Baliakas, I Kavakiotis, A Agathangelidis, LA Sutton, E Minga, ...
Clinical Cancer Research 23 (17), 5292-5301, 2017
Mandates: Swedish Research Council, European Commission, Government of Italy
Review
GPR56 contributes to the development of acute myeloid leukemia in mice
D Daria, N Kirsten, A Muranyi, M Mulaw, S Ihme, A Kechter, M Hollnagel, ...
Leukemia 30 (8), 1734-1741, 2016
Mandates: German Research Foundation
Review
NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib
C Wolf, A Garding, K Filarsky, J Bahlo, S Robrecht, N Becker, M Zucknick, ...
International journal of cancer 142 (2), 322-333, 2018
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Review
TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition
S Bamezai, D Demir, AJ Pulikkottil, F Ciccarone, E Fischbein, A Sinha, ...
Leukemia 35 (2), 389-403, 2021
Mandates: German Research Foundation, Helmholtz Association, AIRC Foundation for …
Publication and funding information is determined automatically by a computer program